JoannaACooperMD

PubMed

• 1 citations
  Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.
  Annika Anderson, William Rowles, Shane Poole, Ayushi Balan, Carolyn Bevan, Rachel Brandstadter, Andrea I Ciplea, Joanna Cooper, Michelle Fabian, Thomas W Hale, Dina Ja...> ;Annals of Clinical and Translational Neurology. 2023 Nov 1
• 18 citations
  Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis.
  A. Scott Nielsen, Augusto Miravalle, Annette Langer-Gould, Joanna Cooper, Keith R Edwards, R. Philip Kinkel> ;Multiple Sclerosis. 2012 Mar 1
• 213 citations
  Factors that influence adherence with disease-modifying therapy in MS.
  Katherine Treadaway, Gary Cutter, Amber Salter, Sharon G. Lynch, James Simsarian, John R. Corboy, Douglas Jeffery, Bruce A. Cohen, Ken Mankowski, Joseph Guarnaccia, La...> ;Journal of Neurology. 2009 Apr 27
• 300 citations
  Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
  Jerry S. Wolinsky, Ponnada A. Narayana, Paul O'Connor, P. K. Coyle, Corey C. Ford, Kenneth P. Johnson, Aaron Miller, Lillian Pardo, Shaul Kadosh, David Ladkani, Lorne ...> ;Annals of Neurology. 2007 Jan 1
• 9 citations
  Response of intrathecal baclofen resistance to dose reduction.
  Joanna A. Cooper, Barbara Ridley> ;Neurology. 2006 Oct 24
• 99 citations
  Interferon β-1a for early multiple sclerosis: CHAMPS trial subgroup analyses
  Roy W. Beck, Danielle L. Chandler, Stephen R. Cole, Jack H. Simon, Lawrence Jacobs, R. Philip Kinkel, John B. Selhorst, John W. Rose, Joanna Cooper, George P. A. Rice,...> ;Annals of Neurology. 2002 Apr 1
• Reelin-induced tyrosine [corrected] phosphorylation of disabled 1 during neuronal positioning.
  Howell BW, Herrick TM, Cooper JA> ;Genes Dev.. 1999-03-15
• Rapidly evolving myopathy with myosin-deficient muscle fibers.
  al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J> ;Ann. Neurol.. 1994-03-01
• Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
  Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV> ;Brain. 1992-12-01
• Cognitive components of reaction time in Parkinson's disease.
  Jordan N, Sagar HJ, Cooper JA> ;J. Neurol. Neurosurg. Psychiatr.. 1992-08-01
• 37 citations
  Status epilepticus manifesting as reversible Wernicke's aphasia.
  Robert T. Knight, Joanna Cooper> ;Epilepsia. 1986 Jun 1
• 10 citations
  Autosomal dominant motor system degeneration in a black family
  Joanna Cooper, Tsutomu Nakada, Robert T. Knight, Robert P. Friedland> ;Annals of Neurology. 1983 Nov 1
• Cosmic ray-produced radionuclides as tracers of atmospheric precipitation processes.
  Wogman NA, Thomas CW, Cooper JA, Engelmann RJ, Perkins RW> ;Science. 1968-01-12
• A rapid semi-quantitative method for the assay of tyrosinase activity.
  BROWN FC, COOPER JA> ;Clin. Chim. Acta. 1956-01-01
• IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
  Kinkel, R. P., Kollman, C., O'Connor, P., Murray, T. J., Simon, J., Arnold, D., Bakshi, R., Weinstock-Gutman, B., Brod, S., Cooper, J., Duquette, P., Eggenberger, E., ...> ;Neurology. 2006 Mar 14
• Join now to see all

Journal Articles

• Maximally tolerated vs Minimally Effective Dose: the case of rituximab in MS  
  Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP, Multiple Sclerosis, 8/1/2011
• Factors that influence adherence with disease-modifying therapy in MS  
  . J Neurol, 4/1/2009
• The Functional Index for Living with Multiple Sclerosis: Development and Validation of a New Quality of Life Questionnaire.  
  JM Wesson, JA Cooper, LS Jehle, SN Lockhart, K Draney, J Barber, MULTIPLE SCLEROSIS, 1/1/2009
• Troubleshooting for Intrathecal Baclofen TherapyTouch briefings  
  Cooper, J, US Neurological Disease, 1/1/2007
• Response of Intrathecal Baclofen Resistance to Dose Reduction  
  Cooper, J., Ridley, B., Neurology, 1/1/2006
•  
  Beck, R,, Chandler, D., Cole, S., Simon, J., Jacobs L., Kinkel, P., Selhorst, J., Rose, J., Cooper, J., Rice G., Murray, T., Sandrock, A., Ann Neurol, 1/1/2002
• UPPER AIRWAY OBSTRUCTION FOLLOWING TRANSESOPHAGEAL ECHOCARDIOGRAPHY  
  Saphir, R., Kerbavaz, R., Cooper, J., Schiller, N, Journal of the American Society of Echocardiography, 11/1/1997
• STATUS EPILEPTICUS MANIFESTING AS REVERSIBLE WERNICKE'S APHASIA  
  Knight, R., Cooper, J, Epilepsia, 1/1/1986
• AUTOSOMAL DOMINANT MOTOR NEURON DEGENERATION IN A BLACK FAMILY  
  JA Cooper, T. Nakada, R. Knight, R. Friedland, Annals of Neurology, 11/1/1983
• GLUCOSE INTOLERANCE DURING PREGNANCY; II) A COMPARATIVE STUDY OF DIAGNOSTIC SCREENING METHODS  
  A. Cooper, M. Granat, M. Sharf, Obstetrics and Gynecology, 4/1/1979
• GLUCOSE INTOLERANCE DURING PREGNANCY; I) A REAPPRAISAL OF ALLEGED SCREENING CRITERIA  
  M. Granat, M. Sharf, A. Cooper, Obstetrics and Gynecology, 2/1/1979
• Join now to see all

Abstracts/Posters

• Unique Characteristics of Patients with Multiple Sclerosis Receiving Intrathecal Baclofen Therapy
  JA Cooper, B Ridley, LS Jehle, JM Wesson, Submitted for poster presentation at ECTRIMS 2013, 1/1/2013
• Multiple Sclerosis Disease Severity Correlates with Perception Of Clinic visit effectiveness when using Quality Of Life Assessment
  Sara KosterMark Wesson, Myesha Kirk-Junior, Victoria Nolan, Edward Fox, , Elliot Frohman, Gina Remington, Ardith Courtney, Lynn Jehle, Joanna Cooper, Submitted for poster presentation at ECTRIMS 2013, 1/1/2013
• The Utility Of The Functional Index For Living With Multiple Sclerosis In Clinical Practice
  J cooper et al., ECTRIMS, poster 1051, 10/1/2012
• Cell Depletion and Safety of Low Dose Rituximab in Patients with Relapsing Multiple Sclerosis
  Miravalle AA, Kinkel R, Langer-Gould A, Cooper J. B, American Academy of Neurology, 61st Annual Meeting, April-May, 4/1/2009
• The Functional Index for Living with Multiple Sclerosis: development and preliminary results
  Wesson JM, Cooper JA, Barber J, Lockhart SN, Draney K, Dalio J, Linton A, Multiple Sclerosis, World Conference on Treatment and Research in Multiple Sclerosis, 9/1/2008
• A multivariate analysis of factors that influence adherence with disease-modifying therapy in multiple sclerosis
  Treadaway K, Cutter G, Lynch SG, Corboy J, Simsarian J, Jeffery D, Cohen B, Mankowski K, Guarnaccia JB, Schaeffer L, Brandes D, Kaufman C, Duncan D, Marder E, Allen A,..., Multiple Sclerosis, World Conference on Treatment and Research in Multiple Sclerosis, 9/1/2008
• Efficacy of Alemtuzumab
  oanna A. Cooper, (On behalf of the CAMMS223 Study Group), Relapsing-Remitting Multiple Sclerosis is Independent of Baseline Status Consortium Of MS Centers (C, 5/1/2008
• Join now to see all

Other

• Multiple Sclerosis: A Practice Guide For Primary Care Providers. 
  JA Cooper, C. Figuerito, D. Foti, A Lily, D. Mohr, P Werfel.
  A CME Home Study Course. Alta Bates Medical Center and The Northern California Chapter of the Nation
• Multiple Sclerosis: A Practice Guide for Primary Care Providers 
  JA Cooper, E. Waubant, R. Young, D. Blanchard, K. Wharton, P. Werfel
  A CME Home Study Course, second edition. Alta Bates Medical Center and The Northern California Chapt